Radiotherapy has been used for several decades to treat cancer and intensive research has made it a powerful and precise treatment for patients today. Although it has dramatically improved over the years, the efficiency of conventional radiotherapy is still limited by the complications and damages caused on normal tissue surrounding the treated area.
FLASH radiotherapy consists in the delivery of very high dose rates in a fraction of a second and has reproducibly shown a healthy tissue sparing effect in several preclinical studies, while still effectively destroying cancerous cells. The very short irradiation time also eliminates any effect of organ or tumor motion: targeting is better controlled.
To help translate this new technique in clinical practice, we are developing FLASHKNiFE: the FLASH radiotherapy system.
This system is not CE marked as a Medical Device.